modular phase i/ii clinical trial evaluating the selective met-kinase inhibitor omo-1 in patient...
Published 5 years ago • 134 plays • Length 3:25Download video MP4
Download video MP3
Similar videos
-
4:48
findings of a phase i/ii study of nivolumab in patients with virus-associated tumours
-
3:21
overview of a phase i clinical trial using bgb-3111 for the treatment of relapsed cll
-
6:45
anti-pd1 or tyrosine kinase inhibitors?
-
39:42
dr martin duddy - a review of current clinical trials in ms
-
30:30
response prediction for a multi tyrosine kinase inhibitor
-
5:41
tyrosine kinase inhibitor in combination with chemo shows benefit in acute myeloid leukaemia
-
2:41
compact phase iii clinical trial results
-
6:08
measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia
-
6:46
case 1: clinical trials in early-stage her2 breast cancer
-
3:58
csf1 inhibition in tsgct: managing adverse events
-
2:42
cediranib and lenalidomide in iodine 131-refractory differentiated thyroid cancer
-
5:01
vegf tki therapy after i/o in mrcc
-
1:53
asc2escalate: phase ii dose-escalation study of second-line asciminib in patients with cml-cp
-
1:41
arcadia: peripheral biomarker analysis in urothelial carcinoma
-
0:30
emerging data on immunotherapies and tyrosine kinase inhibitors in lung cancer: 2022 esmo florida
-
3:32
sat - 13 - clinical trials review 2 (feun)
-
![[9] phase ib study of chemoprevention with green tea polyphenon e and erlotinib-](https://i.ytimg.com/vi/JkWtJ5s2C7k/mqdefault.jpg)
3:00
[9] phase ib study of chemoprevention with green tea polyphenon e and erlotinib-
-
4:33
using btk inhibitors in community practice